Literature DB >> 4565815

A decade of combination chemotherapy of advanced Hodgkin's disease.

V T DeVita, G P Canellos, J H Moxley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4565815     DOI: 10.1002/1097-0142(197212)30:6<1495::aid-cncr2820300613>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  19 in total

Review 1.  Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.

Authors:  Joachim Yahalom
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

Review 2.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 3.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

4.  Radiotherapy in the treatment of Hodgkin's disease.

Authors:  A R Timothy; S B Sutcliffe; A G Stansfeld; P F Wrigley; A E Jones
Journal:  Br Med J       Date:  1978-05-13

5.  Aggressive treatment for Hodgkin's disease.

Authors: 
Journal:  Br Med J       Date:  1973-06-30

6.  Chemotherapy of Hodgkin's disease comes of age.

Authors:  J G McVie; R Somers
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-30

7.  Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.

Authors:  D S Alberts; S E Salmon; H S Chen; T E Moon; L Young; E A Surwit
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

8.  Malignant lymphomas in children.

Authors:  P R Exelby
Journal:  World J Surg       Date:  1980-01       Impact factor: 3.352

9.  The protein binding of vinblastine in the serum of normal subjects and patients with Hodgkin's disease.

Authors:  W H Steele; D J King; H E Barber; G M Hawksworth; A A Dawson; J C Petrie
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Binding of vinblastine to recrystallized human alpha 1-acid glycoprotein.

Authors:  W H Steele; D J Haughton; H E Barber
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.